Xuanwu Hospital, Beijing

This early-stage trial tests whether implanting specially grown dopamine-producing cells into the brain is safe and can help people with Parkinson's disease. Six participants receive their own lab-grown cells placed into a brain region that controls movement. The study measures c…

This study tests whether adding GM1, a natural brain substance, to standard clot-removal treatment helps people recover better after a severe stroke. About 868 adults in China who have a blocked artery in the front part of the brain will receive either GM1 or a placebo daily for …

This study tests whether the drug sivelestat sodium, given alongside standard clot-removal surgery, can help people recover better after a major stroke. The trial will include 868 adults aged 18-80 with large-vessel blockage in the front part of the brain. The goal is to see if t…

This study looks at how well a device called WEB works for treating brain aneurysms (weak spots in blood vessels) in real-life medical practice. It will include 1,000 people of any age who have had this device placed. The main goals are to see if the aneurysm is sealed off at 12 …

This early-stage trial is testing whether a nasal spray containing exosomes from umbilical cord stem cells is safe and might help people with mild to moderate Alzheimer's. The study involves 33 participants and will first test different doses, then compare the best dose to a plac…

This study is testing whether a ketogenic diet (a high-fat, low-carbohydrate diet) can help stop super-refractory status epilepticus—a life-threatening condition where seizures continue despite standard medications. The diet is given via feeding tube or by mouth to 84 ICU patient…

This study tests whether a newer clot-dissolving drug (tenecteplase) works better than the standard drug (alteplase) when given before a mechanical procedure to remove a large blood clot from the brain. About 850 adults who have had a severe stroke within the last 4.5 hours will …

This pilot study tests whether everolimus, a drug usually used for cancer, can help control seizures in people with drug-resistant focal epilepsy. Only 5 adults aged 18-60 will take the drug during seizure events for 12 weeks. The goal is to see if seizure frequency drops and if …

This study tests whether giving a clot-busting drug (tenecteplase) before transferring patients with a severe stroke in the back of the brain (basilar artery occlusion) to a specialized hospital can improve recovery. About 316 adults who had a stroke 4.5 to 24 hours earlier will …

This study looks at whether giving a clot-dissolving drug called Tenecteplase to stroke patients before they are moved to a hospital that can perform a clot-removal procedure improves their recovery. The trial involves 572 adults who had a stroke caused by a large blockage in the…

This study compares standard medical care to a new, less invasive surgery for people with a severe bleeding stroke. The surgery uses a small tube to drain the blood clot and delivers clot-busting medicine directly into the brain. Researchers want to see if this approach helps pat…

This study looks at whether a structured rehabilitation program can delay or reduce the chance of spine degeneration near the surgery site in frail adults aged 75 and older who have had short-segment lumbar fusion. About 212 participants will be randomly assigned to either the re…

This study tests whether performing skull surgery early, before dangerous brain swelling occurs, can improve outcomes for people who have had a severe stroke and are at high risk of swelling. About 380 adults aged 18–75 will be randomly assigned to receive either early surgery pl…

This study tests whether adding batroxobin, a snake venom enzyme that dissolves clots, to standard blood thinners helps people with acute cerebral venous thrombosis (a rare stroke caused by a clot in a brain vein). Seventy-two adults will be randomly assigned to receive either st…

This early-stage trial tests whether exosomes from stem cells can help people recover from a recent stroke. 29 participants will receive either the exosome treatment or a placebo, and researchers will check for safety and any signs of improved function. The study is small and exp…

This study tests whether using a balloon guide catheter during mechanical thrombectomy (a procedure to remove blood clots) can improve blood flow restoration in a single attempt for people with acute ischemic stroke caused by internal carotid artery blockage. About 364 participan…

This early-phase trial is testing whether combining near-infrared light therapy with the drug lecanemab can improve cognitive function in people with mild Alzheimer's disease. Twenty participants will be randomly assigned to receive either real light therapy plus lecanemab or a s…

This Phase 2 trial tests the oral drug everolimus in 10 adults with vascular malformations—abnormal clusters of blood vessels. The goal is to see if the drug can shrink these lesions and reduce complications like bleeding. Participants take everolimus daily for up to a year, with…

This study is testing a new blood test to help doctors diagnose Parkinson's disease and similar brain disorders more accurately and earlier. Researchers will use a technique called RT-QuIC to detect misfolded proteins in blood samples from 458 participants, including healthy peop…

This study looks at whether a special type of CT scan (multimodal CT) can more accurately identify the blocked artery in people with medium vessel occlusion stroke. Researchers will compare this method to standard CT scans in 622 adults who had a stroke within the last 24 hours. …

This nationwide study in China aims to improve early detection of Alzheimer's disease. Researchers will screen 6,000 adults aged 50 and older using a digital cognitive test and a questionnaire, followed by blood tests to confirm Alzheimer's-related changes. The goal is to see if …

This study tests whether giving the pain drug Anrikefon before or during gallbladder surgery works better for reducing pain and helping recovery. 274 adults having laparoscopic gallbladder removal will receive the drug either 15 minutes before anesthesia or right after the gallbl…

This study compares two painkillers given through a patient-controlled pump after brain surgery. The goal is to see if oliceridine causes less nausea than the standard drug sufentanil. 174 adults having surgery near the base of the skull will be randomly assigned to one of the tw…

This study tests whether a device that sends mild electrical currents to the brain (hi-tACS) can improve sleep in people with neuroimmune diseases like multiple sclerosis who also have insomnia. Eighty participants will receive 20 sessions of the stimulation or a sham treatment. …

This phase 3 trial at Xuanwu Hospital in Beijing is testing whether a combination painkiller (oxycodone/acetaminophen) can safely ease chronic pain in 10 people with Alzheimer's disease. Participants will take the medication once daily for 12 weeks, with pain levels and side effe…

This small early-phase study is testing whether galcanezumab, a drug used for migraines, can help people with mild-to-moderate Alzheimer's disease. Ten participants will receive injections over 24 weeks, and researchers will measure changes in thinking, memory, and brain chemical…

This study tests whether a 60-second ultrasound pulse to the brain can improve thinking and memory in people with long COVID brain fog. Forty participants will receive either real or fake (sham) stimulation, and their cognitive performance will be measured before and after. The g…

This study is a large registry that will collect data from over 10,000 people in China diagnosed with a rare condition where abnormal connections form between arteries and veins in the brain or spine. Researchers will track how common the disease is, what treatments are used, and…

This large nationwide study in China will track nearly 10,000 people with Alzheimer's disease to measure the financial and emotional burden on patients and their caregivers. Researchers will collect data on medical expenses, care costs, and lost income. The goal is to fill gaps i…

This study tests a 6-week pre-surgery program for people aged 75 and older who need spine surgery. The program includes exercise, nutrition advice, managing other health conditions, and brain training. Researchers want to see if it helps patients become more independent after sur…

This study is looking back at medical records of 2,600 stroke patients who received clot-busting drugs between 4.5 and 24 hours after their stroke started. The goal is to see if giving the drug later than the usual 4.5-hour window can still lead to good recovery. The study does n…

This study follows 10,000 patients who had a bleeding aneurysm in the brain to learn more about a complication called delayed ischemic neurological deficit (DIND). Researchers will track how doctors diagnose and treat DIND, and compare different treatment approaches to see which …

This study is testing a new, noninvasive MRI technique to see if it can better predict stroke risk in people with narrowed arteries in the brain (ICAS). Researchers will measure blood flow pressure using a special MRI scan and follow 400 participants for one year to see who has a…

This observational study will use combined PET/MR scans to measure blood flow and glucose metabolism in the brains of 200 people with severe carotid artery narrowing. Participants have already had a mini-stroke or stroke in the past year. The goal is to develop better imaging mar…

This study follows 500 adults who had a brain hemorrhage and received surgery to remove the blood clot. Researchers will track their recovery and quality of life over time to see which surgical methods and timings lead to the best outcomes. The goal is to gather information that …